Exhibit 107

Calculation of Filing Fee Table

Form S-3

(Form Type)

Sunshine Biopharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type	Security Class Title	Fee Calculation Rule			Amount Registered(1)			Proposed Maximum Offering Price Per Share			Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee
Equity	Shares of Common Stock, par value $0.001 per share		457	(c)		17,857,143	(2)	$	0.64	(3)	$	11,428,571.52	$	0.0001102	$	1,259.43
Total Offering Amount						17,857,143					$	11,428,571.52			$	1,259.43
Total Fees Previously Paid																—
Total Fee Offsets																—
Net Fee Due															$	1,259.43

(1)	Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the Registrant is also registering hereunder an indeterminate number of additional shares of common stock that shall be issuable pursuant to Rule 416 to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2)	Consists of an aggregate of 17,857,143 shares of the Registrant’s common stock, including (i) 2,450,000 shares of the Registrant’s common stock, (ii) 3,502,381 shares of the Registrant’s common stock issuable upon the exercise of pre-funded warrants, and (iii) 11,904,762 shares of the Registrant’s common stock issuable upon the exercise of warrants.
(3)	Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act and based upon the average of the high and low sale prices of the Registrant’s shares of common stock on the Nasdaq Capital Market on May 23, 2023.